Science Explorer Back to mapMap
Discussion
Company · Toyota · Japan

Toyota Group (Japan)

global.toyota/enROR OpenAlex
Research works
5
▲ 5400% vs 2018-21
Citations
79
14.5 per fractional work
Top-10% rate
3.6%
all institutions 10.0%
Open access
51%
world 40%
International
63%
world 18%
Toyota Group (Japan)

Not ranked overall: Toyota Group (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Toyota Group (Japan) work in?

In all years, 46% of research at Toyota Group (Japan) is in Physical Sciences, 28% in Health Sciences. Its largest fields are Engineering (30%), Medicine (22%), Computer Science (14%).

Physical Sciences: 3 fractional works · 46.1% of its workEngineering: 2 fractional works · 30.1% of its workElectrical and Electronic Engineering: 1 fractional works · 22.4% of its workControl and Systems Engineering: 0 fractional works · 3.1% of its workAutomotive Engineering: 0 fractional works · 1.5% of its workBiomedical Engineering: 0 fractional works · 1.5% of its workMechanical Engineering: 0 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 14.5% of its workComputer Networks and Communications: 1 fractional works · 10.6% of its workSignal Processing: 0 fractional works · 3.5% of its workSmaller subfields together: 0 fractional works · 0.4% of its workEnvironmental Science: 0 fractional works · 1.5% of its workEnvironmental Engineering: 0 fractional works · 1.5% of its workHealth Sciences: 2 fractional works · 28.1% of its workMedicine: 1 fractional works · 22.0% of its workEpidemiology: 0 fractional works · 5.1% of its workOrthopedics and Sports Medicine: 0 fractional works · 3.1% of its workPsychiatry and Mental health: 0 fractional works · 3.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.9% of its workSurgery: 0 fractional works · 2.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.5% of its workPharmacology: 0 fractional works · 1.5% of its workOncology: 0 fractional works · 1.3% of its workNeurology: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 6.1% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 6.1% of its workSocial Sciences: 1 fractional works · 18.0% of its workPsychology: 1 fractional works · 10.3% of its workDevelopmental and Educational Psychology: 0 fractional works · 6.1% of its workClinical Psychology: 0 fractional works · 2.0% of its workSocial Psychology: 0 fractional works · 2.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 4.6% of its workCultural Studies: 0 fractional works · 2.2% of its workDemography: 0 fractional works · 2.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 0 fractional works · 3.1% of its workManagement Information Systems: 0 fractional works · 3.1% of its workLife Sciences: 0 fractional works · 7.9% of its workImmunology and Microbiology: 0 fractional works · 4.6% of its workApplied Microbiology and Biotechnology: 0 fractional works · 4.6% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 3.1% of its workMolecular Medicine: 0 fractional works · 3.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workALL ITS WORKToyota Group(Japan)5fractional works, all years
Life Sciences8%Physical Sciences46%Health Sciences28%Social Sciences18%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Engineering230.1%
    2. Computer Science114.5%
    3. Environmental Science01.5%
    1. Medicine122.0%
    2. Health Professions06.1%
    1. Psychology110.3%
    2. Social Sciences04.6%
    3. Business, Management and Accounting03.1%
    1. Immunology and Microbiology04.6%
    2. Biochemistry, Genetics and Molecular Biology03.1%
    3. Pharmacology, Toxicology and Pharmaceutics00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.89× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 15.05× its world share, 0 worksImmunology and Micro…Engineering: 0.34× its world share, 0 worksEngineeringMedicine: 2.14× its world share, 1 worksMedicinePsychology: 4.42× its world share, 0 worksPsychologySocial Sciences: 1.20× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.1×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Immunology and Microbiology15.05×0 works
  2. Psychology4.42×0 works
  3. Medicine2.14×1 works
  4. Biochemistry, Genetics and Molecular Biology1.89×0 works
  5. Social Sciences1.20×0 works
  6. Engineering0.34×0 works

What are the most cited papers from Toyota Group (Japan)?

The most cited paper from Toyota Group (Japan) is "Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition" (Masaru Miyazaki et al., 2015), with 301 citations. Next come "Biliary tract cancer registry in Japan from 2008 to 2013" (145) and "Feasibility analysis of vehicular dynamic spectrum access via queueing theory model" (16).

Most cited papers
#PaperReleasedCitations
1 Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition Masaru Miyazaki et al. · Journal of Hepato-Biliary-Pancreatic Sciences 18 Mar 2015 301
2 Biliary tract cancer registry in Japan from 2008 to 2013 Shin Ishihara, Akihiko Horiguchi, Shuichi Miyakawa et al. · Journal of Hepato-Biliary-Pancreatic Sciences Open access 23 Dec 2015 145
3 Feasibility analysis of vehicular dynamic spectrum access via queueing theory model Si Chen, Alexander M. Wyglinski, Rama Vuyyuru et al. Conference paper Dec 2010 16
4 Learning in vehicular dynamic spectrum access networks: Opportunities and challenges Si Chen, Rama Vuyyuru, Onur Altintas et al. Conference paper Dec 2011 12
5 Updated clinical practice guidelines for the management of biliary tract cancers: revision concepts and major revised points Hideyuki Yoshitomi, Shuichi Miyakawa, Masato Nagino et al. · Journal of Hepato-Biliary-Pancreatic Sciences Open access 18 Mar 2015 12
All 23 most cited papers, with filters and sorting

Which research topics does Toyota Group (Japan) publish most on?

By volume in 2022-now: Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria, Urinary Tract Infections Management and Sports injuries and prevention.

Antibiotic Use and Resis…0Antibiotic Use and Resistance: 0 fractional worksAntibiotic Resistance in Bacteria: 0 fractional worksUrinary Tract Infections…0Urinary Tract Infections Management: 0 fractional worksSports injuries and prev…0Sports injuries and prevention: 0 fractional worksPosttraumatic Stress Disorder Research: 0 fractional worksSports Dynamics and Biomechanics: 0 fractional worksAntibiotics Pharmacokine…0Antibiotics Pharmacokinetics and Efficacy: 0 fractional worksNosocomial Infections in ICU: 0 fractional worksSMEs Development and Digital Marketing: 0 fractional worksTraumatic Brain Injury R…0Traumatic Brain Injury Research: 0 fractional works
Applied Microbiology and BiotechnologyMolecular MedicineEpidemiologyOrthopedics and Sports Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works
  2. 2 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  3. 3 Urinary Tract Infections Management Epidemiology 0 works
  4. 4 Sports injuries and prevention Orthopedics and Sports Medicine 0 works
  5. 5 Posttraumatic Stress Disorder Research Clinical Psychology 0 works
  6. 6 Sports Dynamics and Biomechanics Biomedical Engineering 0 works
  7. 7 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  8. 8 Nosocomial Infections in ICU Critical Care and Intensive Care Medicine 0 works
  9. 9 SMEs Development and Digital Marketing Demography 0 works
  10. 10 Traumatic Brain Injury Research Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.3%not open48.7%

World: 40% of research is openly available.

with international co-authors63.2%domestic only36.8%

World: 18% is written across borders.

How has Toyota Group (Japan)'s research output changed?

Output in 2022-2025 was 5400% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Toyota Group (Japan) as a percentage of every work published that year, 0.000014% in 2024.

still counting0.000050%0.00010%Toyota Group (Japan)0.0000056% in 20251990200020102020

Fractional works of Toyota Group (Japan) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Toyota

All research institutions in Toyota

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Toyota Group (Japan). Posts are plain text and can be reported.